BSE: 524506 - Coral Laboratories Limited

Rentabilité sur six mois: -19.84%
Rendement en dividendes: +0.23%

Calendrier des promotions Coral Laboratories Limited


À propos de l'entreprise Coral Laboratories Limited

Coral Laboratories Limited manufactures and sells pharmaceutical formulations in India, Ethopia, and internationally.

plus de détails
The company offers antibiotics/antibacterial products, including antifungal, antiemetic, analgesics/antipyretic/antiinflammatory, antispasmodic, anticold, antiallergic, antiasthmatic, antidiabetic, antiemetics, anthelmentic, thyroid, and antiprotozoal/antiamebic products; antimalarial drugs, antipsychotic drugs, gastro-intestinal drugs, kits, muscle relaxants, cough suppressant/expectorant products, cardiovascular medicines, oral antiseptic preparations, mouthwashes, calcium preparations, and appetizers; and nutritional, protein, and iron supplements, as well as other products. It also provides cephalosporin, beta lactam, and lyophilized injectable products; eye/ear/nose drops; nasal sprays and metered dose inhales; and large volume parenteral products. In addition, the company offers various nutraceutical products, such as dietary supplements, herbal/phytochemicals, multivitamins, and nutrients, as well as OTC products. It provides its products in various dosage forms, including tablets, capsules, low RH facilities, liquid orals, liquids and powders, dry syrups, drops, ointment and creams, gels and lotions, granules powders, injectables, nasal sprays, and suppositories. Coral Laboratories Limited was incorporated in 1994 and is headquartered in Mumbai, India.

Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.23
Дивиденд ао 2
Сайт http://corallab.com
Цена ао 757.6
Changement de prix par jour: -2.54% (747.35)
Changement de prix par semaine: -1.55% (739.8)
Changement de prix par mois: -9.81% (807.6)
Changement de prix sur 3 mois: -4.44% (762.2)
Changement de prix sur six mois: -19.84% (908.6)
Changement de prix par an: +93.76% (375.9)
Evolution du prix sur 3 ans: +114.98% (338.8)
Evolution du prix sur 5 ans: +432.03% (136.9)
Evolution des prix sur 10 ans: 0% (728.35)
Evolution des prix depuis le début de l'année: -7.8% (789.95)

Sous-estimation

Nom Signification Grade
P/S 1.72 8
P/BV 0.7979 9
P/E 8.97 9
EV/EBITDA 0 0
Total: 8

Efficacité

Nom Signification Grade
ROA, % 8.31 3
ROE, % 9.5 3
Total: 2

Dividendes

Nom Signification Grade
Div yield, % 0.23 0.58
DSI 0.9286 9.29
Total: 1.91

Devoir

Nom Signification Grade
Debt/EBITDA 0 10
Total: 10

Impulsion de croissance

Nom Signification Grade
Rentabilité Revenue, % 16.32 3
Rentabilité Ebitda, % 0 5
Rentabilité EPS, % 121.44 10
Total: 7.6

Superviseur Titre d'emploi Paiement Année de naissance
Mr. Girish Madanlal Dhameja Whole-Time Director 1981 (44 année)
Ms. Sushma Shashi Kadkade CFO & Non-Exec. Director 1976 (49 années)
Ms. Ruchi Anjaria Company Sec. & Compliance Officer
Mr. Kapil K. Shah Exec. Officer

Adresse: India, Mumbai, #3B Patanwala Industrial Estate - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: http://corallab.com